Amplia Therapeutics Limited

A$0.09As of Sun 8 Nov 2026, 12:00 UTC
ASX:ATXHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (35.11%)
Div yield —
ROE (25.48%)
Biotechnology
Beta (5Y) (0.36)
PE TTM —
TSR TTM (36.43%)
Mkt cap A$45.68M
ROIC (17.23%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.102
15.00%
(70.46%)
Hold 1|12|6|1|0
3Q26
4Q26
1Q27
2Q27
Earnings per share$
—
—
—
—
7.15%
13.44%
18.45%
32.94%
Revenue$M
2.763
2.898
2.899
2.824
4.56%
9.63%
8.60%
1.59%
Peers (US$31.38M)
Cap (US$)
PE
31.51M
—
Capital
TTM
5Y
10Y
Leveragex
6.980
0.076
0.074
EBIT/Intx
0.243
0.065
0.063
Own earn%
(263.59)
(390.32)
(364.89)
Sh yield%
16.27
26.56
27.50
Owners
Insiders/Inst%
5.49
44.85
Short interest%
4.38
SBC / revenue%
0.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
13–19
$1 testx
−0.2
Incr. ROIC%
10